Loading...

SOHO 2026 Annual Meeting

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Home Posters by Code Posters by Title Authors Affiliations Topics Sessions Videos Audios Previous meetings

Topics

Select Topic

Showing 1,267 results.

TCL - 1069

Serum Proteomics Reveals Immunoproteomic Profile Distinguishing Early-Stage Mycosis Fungoides From Atopic Dermatitis

Larisa Geskin

Poster Presenter: Larisa Geskin

Thumbnail for Leukemia Subtype-Specific Patterns of Tumor Lysis Syndrome-Induced Acute Kidney Injury: Incidence, Dialysis Requirement, Mortality, and Healthcare Burden

TCL - 1156

Leukemia Subtype-Specific Patterns of Tumor Lysis Syndrome-Induced Acute Kidney Injury: Incidence, Dialysis Requirement, Mortality, and Healthcare Burden

Krupa Savani

Poster Presenter: Krupa Savani

Previous 1...136 137 138 139 140 141 Next

Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

Thumbnail for Conditional Competing Causes of Death in 5-Year Survivors of Mycosis Fungoides: A SEER Population-Based Landmark Analysis

TCL - 1179

Conditional Competing Causes of Death in 5-Year Survivors of Mycosis Fungoides: A SEER Population-Based Landmark Analysis

Yasir Aziz

Poster Presenter: Yasir Aziz

Thumbnail for Real-World Outcomes of Secondary Hemophagocytic Lymphohistiocytosis in B-Cell Versus T/NK-Cell Lymphomas: A Propensity-Matched Study

TCL - 1219

Real-World Outcomes of Secondary Hemophagocytic Lymphohistiocytosis in B-Cell Versus T/NK-Cell Lymphomas: A Propensity-Matched Study

Muzammil Dastagir

Poster Presenter: Muzammil Dastagir

Thumbnail for Treatment of peripheral T-cell lymphoma with dose-dense, dose-intense chemotherapy as well as Avelumab and Brentuximab Vedutin

TCL - 1227

Treatment of peripheral T-cell lymphoma with dose-dense, dose-intense chemotherapy as well as Avelumab and Brentuximab Vedutin

Maher Salamoon

Poster Presenter: Maher Salamoon

Thumbnail for From Hodgkin Lymphoma to Thymoma: A Comprehensive Map of Second Primary Malignancy Risk in 14,765 CTCL Patients

TCL - 1236

From Hodgkin Lymphoma to Thymoma: A Comprehensive Map of Second Primary Malignancy Risk in 14,765 CTCL Patients

Larisa Geskin

Poster Presenter: Larisa Geskin

Thumbnail for Discordance Between Complete Metabolic Remission and Persistent Bone Marrow Minimal Residual Disease in Primary Cutaneous Gamma-Delta T-Cell Lymphoma: Therapeutic Implications

TCL - 1239

Discordance Between Complete Metabolic Remission and Persistent Bone Marrow Minimal Residual Disease in Primary Cutaneous Gamma-Delta T-Cell Lymphoma: Therapeutic Implications

Marilyne Sily

Poster Presenter: Marilyne Sily

Thumbnail for Treatment Outcomes and Prognostic Factors in Elderly Patients with Newly Diagnosed Peripheral T-Cell Lymphoma

TCL - 1326

Treatment Outcomes and Prognostic Factors in Elderly Patients with Newly Diagnosed Peripheral T-Cell Lymphoma

Omar Elghawy

Poster Presenter: Omar Elghawy

Thumbnail for Second Primary Malignancies in Cutaneous T-Cell Lymphoma: A Retrospective Population-Based Analysis

TCL - 1477

Second Primary Malignancies in Cutaneous T-Cell Lymphoma: A Retrospective Population-Based Analysis

Michael Asare

Poster Presenter: Michael Asare

ePosters in

Topics Sessions

Acute Lymphoblastic Leukemia (ALL)(71)Acute Myeloid Leukemia (AML)(230)Aggressive B-Cell Lymphoma (ABCL)(114)Cellular Therapy (CT)(128)Chronic Lymphocytic Leukemia (CLL)(110)Chronic Myeloid Leukemia (CML)(55)Hodgkin Lymphoma (HL)(54)Indolent B-Cell Lymphoma (IBCL)(47)Mantle Cell Lymphoma (MCL)(23)Multiple Myeloma (MM)(234)

Previous 1 2 Next

Sponsors